The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Revision as of 15:38, 16 June 2009 by Swilliams (talk | contribs) (/* Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky M)
Jump to navigation Jump to search
Atrial fibrillation
ICD-10 I48
ICD-9 427.31
DiseasesDB 1065
MedlinePlus 000184
eMedicine med/184  emerg/46

WikiDoc Resources for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Articles

Most recent articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Most cited articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Review articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Images of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Photos of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Podcasts & MP3s on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Videos on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Evidence Based Medicine

Cochrane Collaboration on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Bandolier on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

TRIP on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Clinical Trials

Ongoing Trials on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation at Clinical Trials.gov

Trial results on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Clinical Trials on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

NICE Guidance on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

NHS PRODIGY Guidance

FDA on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

CDC on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Books

Books on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

News

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in the news

Be alerted to news on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

News trends on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Commentary

Blogs on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Definitions

Definitions of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Patient Resources / Community

Patient resources on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Discussion groups on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Patient Handouts on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Directions to Hospitals Treating The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Risk calculators and risk factors for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Healthcare Provider Resources

Symptoms of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Causes & Risk Factors for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Diagnostic studies for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Treatment of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Continuing Medical Education (CME)

CME Programs on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

International

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation en Espanol

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation en Francais

Business

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in the Marketplace

Patents on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Experimental / Informatics

List of terms related to The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Recommendations for pharmacological rate control during atrial fibrillation [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for preventing thromboembolism [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

Long-term anticoagulation with a vitamin K antagonist is not recommended for primary prevention of stroke in patients below the age of 60 y without heart disease. [1]

Recommendations for pharmacological cardioversion of atrial fibrillation [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendation for pharmacological enhancement of direct-current cardioversion [1]

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for maintenance of sinus rhythm [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with postoperative atrial fibrillation [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with acute myocardial infarction [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with Wolff Parkinson White syndrome (WPW) [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with hyperthyroidism [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for pregnant patients [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with Hypertrophic Cardiomyopathy [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for patients with Pulmonary Hypertension [2]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation- Executive Summary: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidlines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: 700-752. PMID 16908781
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207

Template:SIB


Template:WikiDoc Sources